Pillstats
Rx only · Tablet, Extended Release · Oral

Lithium Carbonate

Lithium Carbonate

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)42351
US makers6 labelers
Packages27
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.065$0.131$0.196$0.262Dec 2025Apr 2026Jul 2026
$0.222
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
6
Active US suppliers
48%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

36K73K109K146K2025 Q12025 Q22025 Q32025 Q42026 Q1
127K
Rx · 2026 Q1
8.4M
Units dispensed
+32%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown8SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown5SUPPLYING
Rising Pharma Holdings, Inc.unknown5SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown3SUPPLYING
American Health Packagingunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.